Selumetinib for lung cancer, postmarket drug safety, screening for thyroid cancer, and more

JAMA Editors' Summary - Un pódcast de JAMA Network - Viernes

Podcast artwork

May 09, 2017 edition of the weekly JAMA Editors' Summary

Visit the podcast's native language site